European healthtech scaleups are focusing on overcoming persistent healthcare challenges by developing solutions for early diagnosis, remote patient monitoring, and innovative therapeutic interventions. In the diagnostics and artificial intelligence sector, Check Point Care utilizes wearable device data to create digital twins that facilitate early medical intervention. Meanwhile, Lithuania-based Ligence leverages machine learning to analyze cardiac ultrasound images, which can potentially reduce routine examination and reporting workflows from 30 minutes to 15 minutes. Both technologies are designed to integrate into existing clinical workflows to alleviate the growing burden on medical professionals.
In the medical devices vertical, Spain-based Anaconda Biomed is developing a specialized catheter system intended to improve clot capture efficiency during stroke treatments, securing a $56 million financing round in September 2026. CorWave, located in France, is building implantable heart pumps featuring a wave membrane inspired by marine animals, aiming to reduce the complication risks associated with conventional devices. The company's system was reportedly implanted in a patient in Australia in May 2025 with initial success.
Addressing biotechnology and advanced therapeutics, Iceland's Arctic Therapeutics combines genetic research with population health data to target underlying mechanisms of rare neurological diseases, raising a €26.5 million Series A in 2025. Sweden-based Asgard Therapeutics is exploring an in vivo cellular reprogramming approach designed to stimulate the body's immune system to recognize and attack malignant tumor cells. Supported by the EIC Scaling Club, these emerging companies are navigating complex regulatory frameworks to translate scientific research into viable clinical products.